🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

ASX-listed Optiscan has revealed a $16.7 million mission to fast-track the development and commercialisation of its revolutionary medical imagery devices. $OIL #OptiscanImaging #BULLSNBEARSWA The West Australian #ASX #Medtech #Healthcare thewest.com.au/business/publi…

We are pleased to advise a study from our clinical research partnership with the Melbourne Dental School has been published in Fontiers in Oncology this week. Read the paper below frontiersin.org/journals/oncol…

Optiscan Imaging has been invited to present its remarkable confocal endomicroscopic medical imaging technology at two key international conferences in North and South America. #BULLSNBEARSWA bit.ly/3XQk8Hy

Pleased to announce our Entitlement Issue has successfully raised a total of $16.7m in funds, with $8.8m from Entitlement applications and $7.9m allocated to underwriters. Read: optiscan.com/investor/asx-a… #optiscanimaging #asx #DigitalPathology

#Medtech company Optiscan secures $16.7m research and development funding $OIL #OptiscanImaging #BULLSNBEARSWA #ASX #3DImaging #SaMD #DigitalPathology #ProlucidTechnologies thewest.com.au/business/publi…

Further coverage in Bulls N' Bears today #digitalpathology #imaginethepossibilities #AI #telepathology

#Medtech company Optiscan has rounded out a dynamic year with a whopping 66 per cent revenue boost to nearly $1.7 million following the sale of its #ViewnVivo research device to an American pharmaceutical company. $OIL The West Australian Prolucid thewest.com.au/business/bulls…

We have released our Annual Report FY23, with revenues increasing to $1.68m (+66%) and net cash outflows decreasing from $3.8m to $3.2m. We thank all our collaborators, shareholders, and employees for their ongoing support & look forward to FY24. optiscan.com/investor/asx-a…

Further coverage by The West Australian. Visit optiscan.com to learn more.

Pleased to announce interim readout on our Breast Cancer Intraoperative Assessment Study, revealing excellent correlation between our real-time #CLE imaging and traditional histological analysis. Read more: lnkd.in/gXYQ8uf2 #optiscanimaging #digitalpathology #asx

Delighted to announce the appointment of Tim Rowe and Shayra Leon as our new Business Development Managers for North America. Read: optiscan.com/investor/asx-a… #asx #optiscanimaging

Delighted to welcome Brendan Fafiani as our new Chief Operating Officer. Mr Fafiani will lead operations at our Melbourne headquarters, our operational planning, commercialisation strategy, customer and development efforts. Read: optiscan.com/investor/asx-a… #optiscanimaging #ASX

Delighted to announce a special report on our company in #stockhead today. Learn more: optiscan.com #optiscanimaging #digitalpathology #imaginethepossibilities stockhead.com.au/health/diagnos…

Optiscan Imaging Ltd has released its Quarterly Report and Appendix 4C for the quarter ended 30 September 2023. Read: optiscan.com/investor/asx-a… #optiscanimaging #asx

Following news about a global shortage of pathologists, we have been featured in a special report by Stockhead today. #optiscanimaging #digitalpathology #imaginethepossibilities Read: stockhead.com.au/tech/optiscans…

Optiscan Imaging Ltd wishes all our US colleagues, clinicians, partners, friends, and their families a wonderful #Thanksgiving. We hope your day is filled with warmth, happiness, and the company of those closest to you.

Delighted to be collaborating with Design + Industry in developing our new product portfolio. With 260 industry awards over 35 years, we look forward to perfecting our new devices for clinicians, health systems and patients. #imaginethepossibilities #digitalpathology

Learn more about our business, technology, and get glimpse into the future of digital pathology and precision surgery in this expert report from Andy Stocker #optiscanimaging #digitalpathology #Robotics

Delighted to be attending #CellBio23 in Boston. Looking forward to connecting with attendees and establishing new connections for our unique handheld, slide-free, non-destructive #viewnvivo single-cell imaging technology. #seelifeconnected #CellBiology #CellBio #optiscanimaging

Good coverage in The West and Bulls N' Bears today. Learn more: optiscan.com #digitalpatholology #imageguidedsurgery #singlecellimaging #imaginethepossibilities #thewest #optiscanimaging #invivage